PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation
Candani S. A. Tutuka,Miles C. Andrews,John M. Mariadason…Volume:
16
Langue:
english
Journal:
Molecular Cancer
DOI:
10.1186/s12943-017-0684-x
Date:
December, 2017
Fichier:
PDF, 867 KB
english, 2017